Drug Type TCR therapy |
Synonyms HRYZ T103, HRYZT103 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Head and Neck Neoplasms | Discovery | CN | 01 Mar 2024 | |
Ovarian Cancer | Discovery | CN | 01 Mar 2024 | |
Sarcoma | Discovery | CN | 01 Mar 2024 |